138 related articles for article (PubMed ID: 38436396)
1. Attitudes toward the American Cancer Society's 2020 cervical cancer screening guidelines: A qualitative study of a national sample of US clinicians.
Michel AD; Fontenot HB; Fuzzell L; Brownstein NC; Lake P; Vadaparampil ST; Perkins RB
Cancer; 2024 Jul; 130(13):2325-2338. PubMed ID: 38436396
[TBL] [Abstract][Full Text] [Related]
2. A cross-sectional survey examining clinician characteristics, practices, and attitudes associated with adoption of the 2019 American Society for Colposcopy and Cervical Pathology risk-based management consensus guidelines.
Vadaparampil ST; Fuzzell LN; Brownstein NC; Fontenot HB; Lake P; Michel A; McIntyre M; Whitmer A; Perkins RB
Cancer; 2023 Sep; 129(17):2671-2684. PubMed ID: 37221653
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.
Fontham ETH; Wolf AMD; Church TR; Etzioni R; Flowers CR; Herzig A; Guerra CE; Oeffinger KC; Shih YT; Walter LC; Kim JJ; Andrews KS; DeSantis CE; Fedewa SA; Manassaram-Baptiste D; Saslow D; Wender RC; Smith RA
CA Cancer J Clin; 2020 Sep; 70(5):321-346. PubMed ID: 32729638
[TBL] [Abstract][Full Text] [Related]
4. The ASCCP Cervical Cancer Screening Task Force Endorsement and Opinion on the American Cancer Society Updated Cervical Cancer Screening Guidelines.
Marcus JZ; Cason P; Downs LS; Einstein MH; Flowers L
J Low Genit Tract Dis; 2021 Jul; 25(3):187-191. PubMed ID: 34138787
[TBL] [Abstract][Full Text] [Related]
5. Factors Associated With Guideline-concordant and Excessive Cervical Cancer Screening: A Mixed Methods Study.
Perkins RB; Fuzzell L; Lake P; Brownstein NC; Fontenot HB; Michel A; Whitmer A; Vadaparampil ST
Womens Health Issues; 2024; 34(3):257-267. PubMed ID: 38383228
[TBL] [Abstract][Full Text] [Related]
6. Leveraging COVID-era innovation for cervical cancer screening: Clinician awareness and attitudes toward self-sampling and rapid testing for HPV detection.
Rodriguez NM; Brennan LP; Claure L; Balian LN; Champion VL; Forman MR
PLoS One; 2023; 18(3):e0282853. PubMed ID: 36893182
[TBL] [Abstract][Full Text] [Related]
7. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
8. Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists.
Perkins RB; Anderson BL; Gorin SS; Schulkin JA
Am J Prev Med; 2013 Aug; 45(2):175-81. PubMed ID: 23867024
[TBL] [Abstract][Full Text] [Related]
9. Are Health Care Professionals Prepared to Implement Human Papillomavirus Testing? A Review of Psychosocial Determinants of Human Papillomavirus Test Acceptability in Primary Cervical Cancer Screening.
Tatar O; Wade K; McBride E; Thompson E; Head KJ; Perez S; Shapiro GK; Waller J; Zimet G; Rosberger Z
J Womens Health (Larchmt); 2020 Mar; 29(3):390-405. PubMed ID: 31479381
[No Abstract] [Full Text] [Related]
10. Clinicians' attitude towards changes in Australian National Cervical Screening Program.
Yap D; Liang X; Garland SM; Hartley S; Gorelik A; Ogilvie G; Tan J; Wrede CDH; Jayasinghe Y
J Clin Virol; 2016 Mar; 76 Suppl 1():S81-S87. PubMed ID: 26651602
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening, abnormal cytology management, and counseling practices in the United States.
Irwin K; Montaño D; Kasprzyk D; Carlin L; Freeman C; Barnes R; Jain N; Christian J; Wolters C
Obstet Gynecol; 2006 Aug; 108(2):397-409. PubMed ID: 16880312
[TBL] [Abstract][Full Text] [Related]
12. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
Saslow D; Solomon D; Lawson HW; Killackey M; Kulasingam SL; Cain JM; Garcia FA; Moriarty AT; Waxman AG; Wilbur DC; Wentzensen N; Downs LS; Spitzer M; Moscicki AB; Franco EL; Stoler MH; Schiffman M; Castle PE; Myers ER; Chelmow D; Herzig A; Kim JJ; Kinney W; Herschel WL; Waldman J
J Low Genit Tract Dis; 2012 Jul; 16(3):175-204. PubMed ID: 22418039
[TBL] [Abstract][Full Text] [Related]
13. HPV self-collection: what are we waiting for? Exploration of attitudes from frontline healthcare providers.
Bohn JA; Fitch KC; Currier JJ; Bruegl A
Int J Gynecol Cancer; 2022 Dec; 32(12):1519-1523. PubMed ID: 36351745
[TBL] [Abstract][Full Text] [Related]
14. Human Papillomavirus Testing by Veterans Administration Women's Health Providers: Are They Adhering to Guidelines?
Hallett LD; Gerber MR
J Womens Health (Larchmt); 2018 Feb; 27(2):179-182. PubMed ID: 28885082
[TBL] [Abstract][Full Text] [Related]
15. Mapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention.
Obel J; McKenzie J; Buenconsejo-Lum LE; Durand AM; Ekeroma A; Souares Y; Hoy D; Baravilala W; Garland SM; Kjaer SK; Roth A
Asian Pac J Cancer Prev; 2015; 16(8):3435-42. PubMed ID: 25921158
[TBL] [Abstract][Full Text] [Related]
16. Differences among primary care physicians' adherence to 2009 ACOG guidelines for cervical cancer screening.
Corbelli J; Borrero S; Bonnema R; McNamara M; Kraemer K; Rubio D; Karpov I; McNeil M
J Womens Health (Larchmt); 2014 May; 23(5):397-403. PubMed ID: 24380500
[TBL] [Abstract][Full Text] [Related]
17. Recent changes in cervical cancer screening guidelines: U.S. women's willingness for HPV testing instead of Pap testing.
Thompson EL; Galvin AM; Daley EM; Tatar O; Zimet GD; Rosberger Z
Prev Med; 2020 Jan; 130():105928. PubMed ID: 31756351
[TBL] [Abstract][Full Text] [Related]
18. "If you can't treat HPV, why test for it?" Women's attitudes to the changing face of cervical cancer prevention: a focus group study.
McRae J; Martin C; O'Leary J; Sharp L;
BMC Womens Health; 2014 May; 14():64. PubMed ID: 24885650
[TBL] [Abstract][Full Text] [Related]
19. Change in Provider Beliefs Regarding Cervical Cancer Screening Intervals After an Educational Intervention.
Benard VB; Greek A; Roland KB; Hawkins NA; Lin L; Saraiya M
J Womens Health (Larchmt); 2016 May; 25(5):422-7. PubMed ID: 27096534
[TBL] [Abstract][Full Text] [Related]
20. Perceived effectiveness of HPV test as a primary screening modality among US providers.
Cooper CP; Saraiya M
Prev Med; 2015 Sep; 78():33-7. PubMed ID: 26116889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
